These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6423972)

  • 1. Immunochemical structure of the hepatitis B surface antigen vaccine--I. Treatment of immobilized HBsAg by dissociation agents with or without enzymatic digestion and identification of polypeptides by protein blotting.
    Pillot J; Petit MA
    Mol Immunol; 1984 Jan; 21(1):53-60. PubMed ID: 6423972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical structure of the hepatitis B surface antigen vaccine--II. Analysis of antibody responses in human sera against the envelope proteins.
    Petit MA; Maillard P; Capel F; Pillot J
    Mol Immunol; 1986 May; 23(5):511-23. PubMed ID: 3748012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiments for the development of a hepatitis B vaccine: immunogenicity of HBsAg in guinea pigs (author's transl)].
    Stamm B; Gerlich W; Thomssen R
    Med Microbiol Immunol; 1979 May; 167(2):83-97. PubMed ID: 572908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of the immunogenic activity of hepatitis B surface antigen (HBsAg) and HBsAg polypeptides.
    Sanchez Y; Ionescu-Matiu I; Melnick JL; Dreesman GR
    J Med Virol; 1983; 11(2):115-24. PubMed ID: 6842190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of hepatitis B surface antigen components solubilized with Triton X-100.
    Skelly J; Howard CR; Zuckerman AJ
    J Gen Virol; 1979 Sep; 44(3):679-89. PubMed ID: 93617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.
    Steward MW; Sisley BM; Stanley C; Brown SE; Howard CR
    Clin Exp Immunol; 1988 Jan; 71(1):19-25. PubMed ID: 3349646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purity, antigenicity and immunogenicity of the hepatitis B surface antigen purified by five different methods.
    Fields HA; Bruguera P; de la Torre N; Puig J; Anderson LJ
    J Virol Methods; 1988 Dec; 22(2-3):283-94. PubMed ID: 3220926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of a firm association between hepatitis B surface antigen proteins bearing polymerized human albumin binding sites and core-specific determinants in serum hepatitis B viral particles.
    Petit MA; Capel F; Pillot J
    Mol Immunol; 1985 Nov; 22(11):1279-87. PubMed ID: 2417111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B vaccine: characterization of the polypeptides of hepatitis B surface antigen (author's transl)].
    Barin F; André M; Coursaget P; Gutman N; Hubert M; Goudeau A; Maupas P
    Ann Microbiol (Paris); 1979; 130 A(4):505-10. PubMed ID: 507623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural relationships between the surface antigens of ground squirrel hepatitis virus and human hepatitis B virus.
    Gerlich WH; Feitelson MA; Marion PL; Robinson WS
    J Virol; 1980 Dec; 36(3):787-95. PubMed ID: 7463556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major polypeptide of duck hepatitis B surface antigen particles.
    Marion PL; Knight SS; Feitelson MA; Oshiro LS; Robinson WS
    J Virol; 1983 Nov; 48(2):534-41. PubMed ID: 6620467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccine prepared from the 22 nm particles of surface hepatitis B antigen (HBsAg).
    Karelin VP; Babaeva EE; Gubenko EF; Kaulen DK; Zhdanov VM
    J Med Virol; 1980; 5(4):331-41. PubMed ID: 7229622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of polyalbumin receptors with hepatitis B surface antigen polypeptides in human sera.
    Gilja BK; Keh WC; Kasambalides EJ; Thung SN; Gerber MA
    Arch Pathol Lab Med; 1986 Nov; 110(11):1021-4. PubMed ID: 3022667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic relationship of a hepatitis B surface antigen-derived polypeptide and human serum albumin.
    Sanchez Y; Ionescu-Matiu I; Hollinger FB; Melnick JL; Dreesman GR
    J Gen Virol; 1980 Jun; 48(Pt 2):273-83. PubMed ID: 6156994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nature of polypeptides larger in size than the major surface antigen components of hepatitis b and like viruses in ground squirrels, woodchucks, and ducks.
    Feitelson MA; Marion PL; Robinson WS
    Virology; 1983 Oct; 130(1):76-90. PubMed ID: 6636542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a monoclonal assay for hepatitis B surface antigen: identification of "HBsAg-like" polypeptides non-reactive in conventional radioimmunoassays.
    Karayiannis P; Goodall AH; Waters JA; Galpin S; Lok A; Thorp R; Thomas HC
    J Med Virol; 1985 Mar; 15(3):291-303. PubMed ID: 3884735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precipitability and composition of HBsAg-anti-HBs immune complexes formed in the presence of complement. A model of circulating immune complex analysis.
    Anh-Tuan N; Falus A; Füst G; Merétey K; Medgyesi GA; Hollán SR
    J Immunol Methods; 1983 Nov; 64(3):283-94. PubMed ID: 6366055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 49,000-dalton polypeptide bearing all antigenic determinants and full immunogenicity of 22-nm hepatitis B surface antigen particles.
    Mishiro S; Imai M; Takahashi K; Machida A; Gotanda T; Miyakawa Y; Mayumi M
    J Immunol; 1980 Apr; 124(4):1589-93. PubMed ID: 6154075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B surface antigen polypeptide micelles from antigen expressed in Saccharomyces cerevisiae.
    Howard CR; Young PR; Lee S; Dixon J; Zuckerman AJ; McAleer WJ; Lehman ED
    J Virol Methods; 1986 Aug; 14(1):25-35. PubMed ID: 2945830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
    Shiau AL; Murray K
    J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.